TCL Archive Phase III Trial Shows Benefit For Old Drugs, Old Device, For Ovarian Cancer, But Will Practice Change? January 20, 2006
TCL Archive US Preventive Services Task Force To Downgrade PSA Screening From “I” to “D” — As In “Don’t Do it.” October 6, 2011
TCL Archive Aranesp Approval Introduces Competition To $1.8 Billion U.S. Cancer Anemia Market August 2, 2002
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
